In terms of value, the squalene market is estimated to grow from USD 141 million in 2022 to USD 202 million by 2028, at a CAGR of 6.34%. Squalene is a natural organic compound that is a type of hydrocarbon and is found in various sources, including shark liver oil, plant oils, and others. According to certain studies, squalene have potential health advantages. Due to its purported antioxidant and anti-inflammatory characteristics, it is occasionally marketed as a dietary supplement.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=542345
The key players profiled in the report include Amyris, Inc (US), SOPHIM (France), Merck KGaA (Germany), Kishimoto Special Liver Oil Co., Ltd. (Japan), Empresa Figueirense De Pesca (Portugal), Arbee (India), Cibus (US), Otto Chemie Pvt. Ltd. (India), Arista Industries (US), and Oleicfat s.l. (Spain). The squalene market is witnessing growth in the past few years; new technologies drive the growth of this market. Market players are introducing new technologies and features to acquire larger market shares.
Merck KGaA operates in a wide range of sectors and offers various products in pharmaceutical and biological prescription drugs to treat cancer, multiple sclerosis (MS), infertility, and growth disorders; cardiovascular and metabolic diseases tools; research-grade chemicals; and equipment for academic labs, biotech, and biopharmaceutical sectors. The company’s business can be divided into three main divisions: Healthcare, Life Science, and Electronics. Merck KGaA has a global presence in Europe, North America, Latin America, Africa and Middle East.
Amyris, Inc. is a biotechnology company based in Emeryville, California, United States. The company specializes in synthetic biology and produces a wide range of sustainable and renewable products, primarily using microorganisms and genetic engineering. Amyris Inc operates through three business segments namely; renewable products, licenses and royalties, and collaborations, grants and other. It offers squalene through the renewable products segment. The products of the Amyris Inc., reach more than 300 million consumers in South America, North America, Europe, and Asia Pacific.
The squalene market is segmented by source into animal (shark liver oil), vegetable (olive oil, palm oil, amaranth oil), and biosynthetic (GM yeast). It finds applications across cosmetics, food, and pharmaceutical industries, with each segment catering to specific consumer needs and regulatory requirements.
Cosmetics are anticipated to emerge as the largest end-use industry for squalene in terms of value during the forecast period. This trend reflects the increasing demand for squalene in skincare and beauty products due to its moisturizing, anti-aging, and skin-repair properties, driving growth in the cosmetics sector.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=542345
Europe emerges as the dominant market for squalene, leading in terms of market value. This trend reflects the region’s robust demand for squalene-based products across various industries, driven by factors such as rising consumer awareness of skincare benefits and stringent regulatory standards promoting natural ingredients.
During the forecast period, North America is projected to emerge as the second-largest market for squalene in terms of value. This region showcases significant demand for squalene-based products, driven by factors such as growing consumer awareness of skincare benefits and the expansion of the cosmetics and pharmaceutical industries.
